Toth Financial Advisory Corp Has $6.73 Million Position in UnitedHealth Group Incorporated $UNH

Key Points

• Toth Financial Advisory Corp increased its holdings in UnitedHealth Group by 9.0%, acquiring an additional 1,780 shares, bringing its total to 21,575 shares valued at approximately $6.73 million.
• Several institutional investors made significant adjustments to their positions in UnitedHealth Group, with GAMMA Investing LLC raising its stake by an astounding 56,142.1%.
• UnitedHealth Group recently reported quarterly earnings of $4.08 EPS, falling short of analysts' estimates, alongside a revenue of $111.62 billion, which was slightly below expectations.

Toth Financial Advisory Corp increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 9.0% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,575 shares of the healthcare conglomerate's stock after buying an additional 1,780 shares during the quarter. Toth Financial Advisory Corp's holdings in UnitedHealth Group were worth $6,731,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Bayforest Capital Ltd raised its holdings in UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after buying an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd boosted its stake in shares of UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after buying an additional 50 shares during the last quarter. Copia Wealth Management bought a new position in UnitedHealth Group in the 4th quarter valued at about $42,000. IAG Wealth Partners LLC bought a new position in shares of UnitedHealth Group during the first quarter worth approximately $42,000. Finally, O Brien Wealth Partners LLC boosted its position in UnitedHealth Group by 74.0% in the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate's stock valued at $46,000 after buying an additional 37 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of recent analyst reports. Royal Bank Of Canada reduced their price objective on shares of UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating for the company in a research report on Wednesday, July 30th. Sanford C. Bernstein lifted their price target on shares of UnitedHealth Group from $337.00 to $379.00 and gave the stock an "outperform" rating in a research note on Friday, September 5th. UBS Group restated a "buy" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Cantor Fitzgerald restated an "overweight" rating and issued a $440.00 price target on shares of UnitedHealth Group in a report on Tuesday, August 26th. Finally, JPMorgan Chase & Co. cut their price target on shares of UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating for the company in a report on Wednesday, August 6th. Sixteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of "Moderate Buy" and a consensus price target of $358.95.

UnitedHealth Group Price Performance

UNH traded up $1.90 on Friday, hitting $336.72. 13,528,738 shares of the company were exchanged, compared to its average volume of 13,684,542. The firm has a market capitalization of $304.96 billion, a P/E ratio of 14.59, a price-to-earnings-growth ratio of 2.20 and a beta of 0.44. The business's fifty day moving average is $295.67 and its 200 day moving average is $363.56. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same quarter last year, the firm posted $6.80 earnings per share. The company's revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.6%. UnitedHealth Group's dividend payout ratio is 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.